Enlivex Therapeutics Ltd. (ENLV) – FDA
-
Enlivex Therapeutics (ENLV) Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra
-
Enlivex (ENLV) Reports Positive DSMB Recommendation and IMOH Clearance to Continue Phase I/II Trial of Allocetra with Chemotherapy
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to ENLV Stock Lookup